Skip to main content
European Commission logo print header

SCS – a self-cleaning shunt for the continuous prevention of shunt blockage in hydrocephalus and NPH patients

Project description

Micro-robotics technologies to treat hydrocephalus condition

Hydrocephalus is a medical condition characterised by a build-up of fluid in the cavities within the brain. Hundreds of thousands of people suffer from this condition, which causes increased intracranial pressure inside the skull, progressive enlargement of the cranium, convulsion, tunnel vision, mental disability, and can be fatal. The good news is that it’s the only common form of dementia reversible by surgical treatment. The EU-funded Microbot Medical project proposes an innovative and disruptive robotic shunt able to improve the quality of life of millions of patients globally. The system advances micro robotics technologies to perform surgical procedures within the human body, offering physicians less invasive and more precise solutions and contributing to lowering the number of surgeries.

Objective

"Microbot Medical is an award-winning start up in the medical device field that was lounched in 2010 by an expert team with extensive experience in clinical practice, mechanical engineering, electronics and business development. Althouogh based in Israel, we have been building our international projection since inception, developing a first of its kind, innovative and disruptive ropotic shunt that will be able to improve the quality of life of millions of patients globally by advancing micro-robotics technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions.
Hydrocephalus, also known as ""water in the brain"" is a medical condition in which there an abnormal accumulation of cerebrospinal fluid in the ventricles of the brain. An estimated 750,000 people are living with it in the US alone, with similar numbers in Europe. It causes increased intracranial pressure inside the skill and progressive enlargement of the head, convulsion, tunnel vision, and mental disability, as well as death. It is the only common form of dementia that is reversible.
Treatment is done by implanting shunts, used to drain excess fluids from patients brain, but are needed to be replaced regularly in surgery.
Microbot Medical's SCS will help lower the number of surgeries done annually around the world, estimated at over 40,000 in the US alone (once every 15 minutes) – with similar number in the EU, with a total cost of over $2B."

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

MICROBOT MEDICAL LTD
Net EU contribution
€ 50 000,00
Address
HAMADA 2
20692 YOKNEAM
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00